Hemorrhagic gastritis as a new dose-limiting toxicity of recombinant tumor necrosis factor.
Krigel
R L
RL
Department of Medical Oncology, Fox Chase Cancer Center, Philadelphia, PA.
Padavic-Shaller
K A
KA
Rudolph
A A
AA
Young
J D
JD
Weiner
L M
LM
Konrad
M
M
Comis
R L
RL
D004305:Dose-Response Relationship, Drug; D004730:Endothelium, Vascular / Q000187:drug effects; D005756:Gastritis / Q000139:chemically induced*; D006471:Gastrointestinal Hemorrhage / Q000139:chemically induced*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D011994:Recombinant Proteins / Q000008:administration & dosage / Q000009:adverse effects; D014409:Tumor Necrosis Factor-alpha / Q000008:administration & dosage / Q000009:adverse effects*
D011994:Recombinant Proteins; D014409:Tumor Necrosis Factor-alpha